Hypoadiponectinemia: A useful marker of dyslipidemia in women with polycystic ovary syndrome

Taiwanese Journal of Obstetrics and Gynecology

Volumn 51, Issue 4, 2012, Pages 583-590

  Chang, Chih Yuan ^a,b   Chen, Mei Jou ^a,c   Yang, Wei Shiung ^a,c   Yeh, Ching Ying ^d   Ho, Hong Nerng ^a   Chen, Shee Uan ^a   Yang, Yu Shih ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adiponectin; Dyslipidemia; High density lipoprotein cholesterol; Hypoadiponectinemia; Polycystic ovary syndrome; Triglycerides

Indexed keywords

ADIPONECTIN; CHOLESTEROL; ESTRADIOL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; DIET RESTRICTION; DYSLIPIDEMIA; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; HYPOADIPONECTINEMIA; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OVARY POLYCYSTIC DISEASE; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; LOGISTIC MODELS; METABOLISM, INBORN ERRORS; MODELS, BIOLOGICAL; ODDS RATIO; POLYCYSTIC OVARY SYNDROME; SEX HORMONE-BINDING GLOBULIN; TAIWAN; TRIGLYCERIDES; YOUNG ADULT;

EID: 84871721695     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2012.09.014     Document Type: Article

References (42)

1. Geisthovel F., Rabe T. The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS)-an extended critical analysis. Reprod Biomed Online 2007, 14:522-535.
2. Norman R.J., Dewailly D., Legro R.S., Hickey T.E. Polycystic ovary syndrome. Lancet 2007, 370:685-697.
3. Hopkinson Z.E., Sattar N., Fleming R., Greer I.A. Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology. BMJ 1998, 317:329-332.
4. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004, 81:19-25. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
5. Wei H.J., Young R., Kuo I.L., Liaw C.M., Chiang H.S., Yeh C.Y. Prevalence of insulin resistance and determination of risk factors for glucose intolerance in polycystic ovary syndrome: a cross-sectional study of Chinese infertility patients. Fertil Steril 2009, 91:1864-1868.
6. Rajkhowa M., Neary R.H., Kumpatla P., Game F.L., Jones P.W., Obhrai M.S., et al. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1997, 82:3389-3394.
7. Corti M.C., Guralnik J.M., Salive M.E., Harris T., Field T.S., Wallace R.B., et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 1995, 274:539-544.
8. Boden W.E. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 2000, 86:19L-22L.
9. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749.
10. Hu E., Liang P., Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996, 271:10697-10703.
11. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996, 221:286-289.
12. Nakano Y., Tobe T., Choi-Miura N.H., Mazda T., Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996, 120:803-812.
13. Okamoto Y., Kihara S., Funahashi T., Matsuzawa Y., Libby P. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) 2006, 110:267-278.
14. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000, 20:1595-1599.
15. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100:2473-2476.
16. Ardawi M.S., Rouzi A.A. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2005, 83:1708-1716.
17. Carmina E., Orio F., Palomba S., Cascella T., Longo R.A., Colao A.M., et al. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005, 152:389-394.
18. Chen M.J., Yang W.S., Yang J.H., Hsiao C.K., Yang Y.S., Ho H.N. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS. Hum Reprod 2006, 21:2266-2271.
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
20. Liu C.J., Chen P.J., Jeng Y.M., Huang W.L., Yang W.S., Lai M.Y., et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J Hepatol 2005, 43:235-242.
21. Yang W.S., Lee W.J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C.L., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001, 86:3815-3819.
22. Bobbert T., Rochlitz H., Wegewitz U., Akpulat S., Mai K., Weickert M.O., et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 2005, 54:2712-2719.
23. Haque W.A., Shimomura I., Matsuzawa Y., Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 2002, 87:2395-2398.
24. Matsubara M., Maruoka S., Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002, 87:2764-2769.
25. Hulthe J., Hulten L.M., Fagerberg B. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 2003, 52:1612-1614.
26. Hashimoto N., Kanda J., Nakamura T., Horie A., Kurosawa H., Hashimoto T., et al. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism 2006, 55:1653-1657.
27. Im J.A., Kim S.H., Lee J.W., Shim J.Y., Lee H.R., Lee D.C. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults. Metabolism 2006, 55:1546-1550.
28. Altinova A.E., Toruner F., Bukan N., Yasar D.G., Akturk M., Cakir N., et al. Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J 2007, 54:221-226.
29. Liu Y., Retnakaran R., Hanley A., Tungtrongchitr R., Shaw C., Sweeney G. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. J Clin Endocrinol Metab 2007, 92:4313-4318.
30. Schneider J.G., von Eynatten M., Schiekofer S., Nawroth P.P., Dugi K.A. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 2005, 28:2181-2186.
31. Verges B., Petit J.M., Duvillard L., Dautin G., Florentin E., Galland F., et al. Adiponectin is an important determinant of apoA-I catabolism. Arterioscler Thromb Vasc Biol 2006, 26:1364-1369.
32. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007, 13:332-339.
33. Fruchart J.C. Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism. Am J Cardiol 2001, 88:24N-29N.
34. Matsuura F., Oku H., Koseki M., Sandoval J.C., Yuasa-Kawase M., Tsubakio-Yamamoto K., et al. Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver. Biochem Biophys Res Commun 2007, 358:1091-1095.
35. Oku H., Matsuura F., Koseki M., Sandoval J.C., Yuasa-Kawase M., Tsubakio-Yamamoto K., et al. Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver. FEBS Lett 2007, 581:5029-5033.
36. Pilz S., Mangge H., Wellnitz B., Seelhorst U., Winkelmann B.R., Tiran B., et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 2006, 91:4277-4286.
37. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85-89.
38. Miller N.E., La Ville A., Crook D. Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit. Nature 1985, 314:109-111.
39. Stampfer M.J., Krauss R.M., Ma J., Blanche P.J., Holl L.G., Sacks F.M., et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996, 276:882-888.
40. Ulmer H., Kollerits B., Kelleher C., Diem G., Concin H. Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44 649 Austrian men and women. Eur J Cardiovasc Prev Rehabil 2005, 12:433-441.
41. Heliovaara M.K., Strandberg T.E., Karonen S.L., Ebeling P. Association of serum adiponectin concentration to lipid and glucose metabolism in healthy humans. Horm Metab Res 2006, 38:336-340.
42. Ehrmann D.A., Liljenquist D.R., Kasza K., Azziz R., Legro R.S., Ghazzi M.N. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006, 91:48-53.